Primary treatment of diabetic macular edema
Tushar M Ranchod, Stuart L FineScheie Eye Institute, Department, of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USAAbstract: Diabetic macular edema (DME) is a leading cause of vision loss in older Americans. Thermal laser treatment remains the mainstay of treatment for DME. Recently...
Main Authors: | Tushar M Ranchod, Stuart L Fine |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-02-01
|
Series: | Clinical Interventions in Aging |
Subjects: | |
Online Access: | https://www.dovepress.com/primary-treatment-of-diabetic-macular-edema-peer-reviewed-article-CIA |
Similar Items
-
Comparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema
by: Sibel Aksoy, et al.
Published: (2015-06-01) -
Clinical study on effects of the combination of triamcinolone acetonide intravitreous injection with laser on diabetic macular edema
by: Jie Yang, et al.
Published: (2013-05-01) -
Clinical efficacy of triamcinolone acetonide and Ranibizumab in the treatment of diabetic diffuse macular edema
by: Bi-Hua Xie, et al.
Published: (2018-06-01) -
Current Treatments of Diabetic Macular Edema
by: Wei-Chun Chan, et al.
Published: (2011-12-01) -
Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
by: Lokman Balyen, et al.
Published: (2018-01-01)